The National Cancer Institute (NCI) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs announced the launch of a new pilot Regulatory Assistance Program. This first-ever NCI SBIR Regulatory Assistance Program is designed to aid NCI SBIR & STTR Phase II awardees in navigating the regulatory path. The program is part of the NCI’s latest efforts to go beyond funding support and help small businesses bring innovative cancer products to market to ultimately help in the fight against cancer. This competitive program is open to NCI Phase II grantees and contractors with projects that are current, or have ended within the last two years.
Applications will be accepted and reviewed on an on-going basis until 5:00 pm EST, February 4, 2011. Final selection of participants will be made by March 4, 2011.
Once selected, the awardees will be matched with experienced regulatory consultants in the areas of therapeutic and device development who will assist them in creating a comprehensive regulatory plan aimed at optimizing each company’s movement through the FDA approval process.
For more information about new Regulatory Assistance Program and how to apply, please visit: